Certificate of Manufacturing Guarantee: Acceptable Forms in Guatemala

Updated: 2026-11-11 · GRZAN Regulatory Team · Verification date 2026-10-20

1. Key takeaways

Guatemala requires a certificate of manufacturing guarantee issued by the health authority, and the acceptable forms are expressly enumerated in the provisions: BPM (Good Manufacturing Practices), standards approval, ISO certificates, FDA, DGKC or IFCC (Article 6.12.6 of NT-37; Article 4.1.5 of NT-40, which on the reagent side lists BPM, ISO 9001, FDA, DGKC and IFCC). The decisive qualifier is the phrase «emitido por la autoridad sanitaria» — issued by the competent authority — rather than a quality system certificate issued by any commercial certification body on its own initiative. This distinction between the issuer and the certificate name is the single most common point of confusion for foreign manufacturers, many of whom hold a private ISO 13485 certificate and assume that it satisfies the requirement automatically. It does not, unless the authority dimension of the requirement is also satisfied, and the difference determines whether the document clears the formal admissibility screen or draws a deficiency.

2. Legal basis

The relevant provisions of the two standards read as follows.

DocumentProvisionContent
NT 37, Versión 5-2016 (2016-02-22)Article 5.1.6Certificate of Good Manufacturing Practices or other equivalent sanitary standards (Certificado de Buenas Prácticas de Manufactura u otras Normas Sanitarias homólogas)
NT 37, Versión 5-2016Article 6.12.6When adding an alternative manufacturing plant, a certificate of manufacturing guarantee issued by the health authority must be submitted: BPM, Aprobación de Normas, Certificado ISO, FDA, DGKC or IFCC
NT 37, Versión 5-2016Article 10.3Where the Good Manufacturing Practices certificate or the manufacturing authorisation document has expired, no registration is granted
NT 40, Versión 3-2015Article 4.1.5Reagent side: original certificate of manufacturing guarantee issued by the health authority (BPM, Certificado ISO 9001, FDA, DGKC o IFCC)

3. Expert insights

Insight one: the operative point of the provisions is the issuing body, not the certificate name. Both Article 6.12.6 and Article 4.1.5 read «emitido por la autoridad sanitaria» — issued by the health authority — and only then enumerate the concrete forms such as BPM, ISO and FDA. This means that an ISO 13485 certificate conforms to the requirement only where the endorsement or recognition of the health authority can be demonstrated; a quality system certificate issued purely by a commercial organisation is not the «certificate of manufacturing guarantee» referred to in the provisions. Companies should therefore trace the chain from the certifying body back to a governmental authority before relying on any document in this slot.

Insight two: the enumerations on the device side and the reagent side differ slightly. Article 4.1.5 of NT-40 reads «Certificado ISO 9001», while Article 6.12.6 of NT-37 reads «Certificado ISO» without specifying a version. Both enumerations include FDA, DGKC and IFCC; the latter two are international organisations in the field of clinical laboratory science, and their appearance in the reagent standard is natural, while their appearance in the alternative plant provision of the device standard shows that the authority keeps an open attitude towards the sources of evidence for a new plant.

Insight three: the wording of Article 5.1.6 is the broadest. New device registrations use the formulation «BPM or other equivalent sanitary standards (otras Normas Sanitarias homólogas)», which is broader than the item-by-item enumeration of Article 6.12.6. For a new registration, an argument can be built first on the «equivalent sanitary standards» pathway, whereas when adding an alternative manufacturing plant the document must be matched against the specific enumeration of Article 6.12.6 item by item, leaving less interpretive room.

Insight four: expiry triggers refusal of registration here as well. Article 10.3 lists the expiry of the Good Manufacturing Practices certificate or the manufacturing authorisation document among the situations in which no registration is granted. This certificate belongs, together with the free sale certificate and the power of attorney, to the group of three time-sensitive documents that must be tightly controlled in the project schedule and tracked in a single validity register. Renewal planning should treat the certificate’s expiry date, not the registration’s expiry date, as the binding constraint when refreshing the document set.

Read together, the four provisions describe a layered evidentiary scheme. The broad formulation of Article 5.1.6 governs the initial registration and leaves room for equivalence arguments; the enumerations of Article 6.12.6 and Article 4.1.5 govern the situations where the authority wants a fixed, checkable list; and Article 10.3 enforces the whole structure by making lapse of the document an independent ground for refusal. A company that maps its own certificates against this scheme — identifying which article each document is filed under, which issuer stands behind it, and when it expires — converts an ambiguous requirement into a fully predictable document plan.

4. Practical recommendations

  • Before obtaining the certificate, establish the requirement that it be issued by the health authority, and do not substitute a third-party quality system certificate directly.
  • For new device registrations, invoke the «equivalent sanitary standards» pathway of Article 5.1.6; when adding an alternative plant, match each item against Article 6.12.6.
  • On the reagent side, select the form under Article 4.1.5 from BPM, ISO 9001, FDA, DGKC or IFCC.
  • Manage the certificate of manufacturing guarantee, the free sale certificate and the power of attorney together in a single validity register.
  • Where the certificate is not in Spanish, arrange sworn translation in parallel.

5. Verification checklist

  • □ It has been confirmed that the certificate is issued by the health authority or demonstrably carries its endorsement
  • □ The new device registration has been prepared under Article 5.1.6
  • □ The addition of an alternative plant has been matched item by item against Article 6.12.6
  • □ The reagent side has selected the form under Article 4.1.5
  • □ The certificate is valid on the day of submission
  • □ The three time-sensitive documents have been brought into a single register
  • □ Sworn translation has been arranged for non-Spanish certificates

Regulatory information verified as of 29 October 2026.

How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support for the Guatemalan market. Our team manages Ministry of Public Health and Social Assistance (MSPAS) registrations, coordinates import and distributor requirements, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com

Disclaimer

Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.

About GRZAN

GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.

GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.

Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.

What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.

Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.

Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.

Take your devices global with GRZAN

We work with manufacturers worldwide to open new markets with a clear regulatory pathway.

Contact us
WhatsApp
QR Code
WhatsApp QR Code
Scan to chat on WhatsApp
Phone
Call
Office Mon-Fri 9:00-18:00
0755-88659477
Mobile 24/7 Service
+86 15816864648
Email
Mail